Dr. Patrick M. Moriarty is an internal medicine professor at the University of Kansas Medical Center in Kansas City, Kansas. He is also the Director of Clinical Pharmacology at the Atherosclerosis/ Lipid Apheresis Center. He has authored or co-authored over 100 articles, abstracts, and chapters in peer review journals.
His research activities include atherosclerosis, Lipid-Apheresis, vascular inflammation, and hemorheology. He has participated in over 100 clinical trials related to dyslipidemia, obesity, hypertension, and diabetes. His clinical activities involve the treatment and diagnosis of atherosclerosis and cardiovascular disease.